Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134807) titled 'A Study on the Impact of LLM-Assisted Follow-up Based on Prompt Engineering for Patients with Diabetes' on Oct. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Fifth Affiliated Hospital, Sun Yat-Sen University
Condition:
Diabetes
Intervention:
Experimental Group:Implement WeChat follow-up assisted by an Active-Inquiry Agent, a Large Language Model driven by prompt engineering.
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-15
Target Sample Size: Experimental Group:44;Control Group:44;
Countries of Recruitment:
China
To know more, visit ...